Gene · 11073
Papers1,761
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,761
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Olivetol induces a non-genotoxic nucleolar DNA damage response via membrane-dependent stress signaling. | Nucleus | 2026 | 42148588 | PubTator, text mining | PubMed |
| TOPBP1-PLK1 interaction preserves genome integrity during mitosis. | Nucleic Acids Res | 2026 | 42109249 | PubTator, text mining | PubMed |
| ATR and TopBP1 oppose to control dormant origin activity and global replication dynamics, providing a first defense against replication stress. | Nucleic Acids Res | 2026 | 42011787 | PubTator, text mining | PubMed |
| Differential sensitivity of MCPH1- and BRCA2-deficient cancer cells to PARP-1 inhibition. | PLoS One | 2026 | 41931484 | PubTator, text mining | PubMed |
| ESCO2 Interacts with TRF1/2 and Facilitates Telomere Maintenance. | Int J Mol Sci | 2026 | 41898498 | PubTator, text mining | PubMed |
| CBX2 phase-separation contributes to homologous recombination repair and drug resistance in ovarian cancer. | Cell Death Dis | 2026 | 41888115 | PubTator, text mining | PubMed |
| Micronuclei: origins, assays, mechanisms, diseases and treatments. | Signal Transduct Target Ther | 2026 | 41888103 | PubTator, text mining | PubMed |
Melanomas arising in blue nevi exhibit absence of TERT promoter mutations, low tumor mutational burden, and high frequency of distant metastases and disease-related mortality: a clinicopathologic and molecular study of 11 cases. | Virchows Arch | 2026 | 41872493 | PubTator, text mining | PubMed |
| The EHMT2-MBLAC2 axis suppresses ribosomal DNA transcription in response to nucleolar DNA damage. | Cell Death Dis | 2026 | 41851073 | PubTator, text mining | PubMed |
| β-tubulin phosphorylation by Chk1 is required for normal spindle formation during cell division. | Commun Biol | 2026 | 41844775 | PubTator, text mining | PubMed |
| TRMT6-directed m1A modification initiates lung squamous cell carcinoma via YTHDF3-stabilized cell cycle genes. | NPJ Precis Oncol | 2026 | 41803297 | PubTator, text mining | PubMed |
| Treatment of pulmonary fibrosis: From disease mechanisms to future novel therapies (Review). | Int J Mol Med | 2026 | 41789674 | PubTator, text mining | PubMed |
| Overcoming acquired doxorubicin resistance of ovarian carcinoma cells by verapamil‑mediated promotion of DNA damage‑driven cytotoxicity. | Int J Oncol | 2026 | 41789585 | PubTator, text mining | PubMed |
| Dysregulation of the DNA damage response by phosphorothioate antisense oligonucleotides. | Nat Commun | 2026 | 41760661 | PubTator, text mining | PubMed |
| Manipulating DNA repair and the DNA damage response to improve cancer therapy. | NAR Cancer | 2026 | 41716447 | PubTator, text mining | PubMed |
| Radiotherapy enhances M1 macrophage immunogenic activity through IFNs induction and stimulation in TP53-wild type tumors. | Cancer Immunol Immunother | 2026 | 41653234 | PubTator, text mining | PubMed |
| Evaluation of protein expression and oxidative stress index in Duchenne muscular dystrophy. | Pediatr Res | 2026 | 41652040 | PubTator, text mining | PubMed |
| RPA-independent activation of the ATR/CHK1 pathway. | Proc Natl Acad Sci U S A | 2026 | 41628322 | PubTator, text mining | PubMed |
| Construction of biomimetic gradient-structured cartilage organoids and mechanistic study of their application for cartilage rejuvenation. | Bioact Mater | 2026 | 41551764 | PubTator, text mining | PubMed |
| Differentiation-dependent proximity proteomics identifies novel host factors linked to HPV16 E2 function. | mBio | 2026 | 41524403 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11073/papers?page=2